Literature DB >> 8262379

Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor.

O Kemper1, D Wallach.   

Abstract

An 809-bp region at the 5' flank of the human p55 tumor necrosis factor receptor (TNF-R)-encoding gene was found to be active in driving expression of the cat reporter gene, indicating that it contains a functional promoter. Deletion analysis showed that the promoter activity is present in the region between nucleotides (nt) -385 and -207; the sequence upstream from this region (nt -809 to -385) has an inhibitory effect. The promoter for the p55 TNF-R resembles housekeeping-type promoters in that it drives transcription from multiple start points (tsp) and lacks canonical TATA and CAAT box motifs. The cluster of tsp lies in a region which is particularly C+T rich. In this region, upstream from and near to the furthest upstream tsp, two closely located TCC repeat motifs were identified. These motifs also appear twice in the promoter for the epidermal growth factor receptor, where they were shown to be essential for promoter activity. The human p55 TNF-R promoter shows an overall resemblance, yet also some marked dissimilarities, to the recently described promoter for the mouse p55 TNF-R.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262379     DOI: 10.1016/0378-1119(93)90095-k

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene.

Authors:  E J Croager; A M Gout; L J Abraham
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.

Authors:  Petra Kleinbongard; Rainer Schulz; Gerd Heusch
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

3.  The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins.

Authors:  Jillian A Bristol; Amanda R Robinson; Elizabeth A Barlow; Shannon C Kenney
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists.

Authors:  B H Yoo; O Masson; Y Li; I A Khan; P S Gowda; K V Rosen
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

5.  Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.

Authors:  H Chan; D P Bartos; L B Owen-Schaub
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1.

Authors:  Thomas E Morrison; Amy Mauser; Aloysius Klingelhutz; Shannon C Kenney
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  CCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.

Authors:  Jillian A Bristol; Thomas E Morrison; Shannon C Kenney
Journal:  Mol Immunol       Date:  2009-06-11       Impact factor: 4.407

8.  Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1.

Authors:  Leen Puimège; Filip Van Hauwermeiren; Sophie Steeland; Sara Van Ryckeghem; Jolien Vandewalle; Sofie Lodens; Lien Dejager; Sofie Vandevyver; Jan Staelens; Steven Timmermans; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  EMBO Mol Med       Date:  2015-08       Impact factor: 12.137

9.  Polymorphisms in the tumor necrosis factor receptor genes affect the expression levels of membrane-bound type I and type II receptors.

Authors:  Sergey V Sennikov; Filipp F Vasilyev; Julia A Lopatnikova; Nadezhda S Shkaruba; Alexander N Silkov
Journal:  Mediators Inflamm       Date:  2014-03-24       Impact factor: 4.711

Review 10.  Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer.

Authors:  Isela Martínez-Reza; Lorenza Díaz; Rocío García-Becerra
Journal:  J Biomed Sci       Date:  2017-12-04       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.